BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 26033696)

  • 1. Candida tropicalis bloodstream infection: Incidence, risk factors and outcome in a population-based surveillance.
    Fernández-Ruiz M; Puig-Asensio M; Guinea J; Almirante B; Padilla B; Almela M; Díaz-Martín A; Rodríguez-Baño J; Cuenca-Estrella M; Aguado JM; ; ;
    J Infect; 2015 Sep; 71(3):385-94. PubMed ID: 26033696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initial use of echinocandins does not negatively influence outcome in Candida parapsilosis bloodstream infection: a propensity score analysis.
    Fernández-Ruiz M; Aguado JM; Almirante B; Lora-Pablos D; Padilla B; Puig-Asensio M; Montejo M; García-Rodríguez J; Pemán J; Ruiz Pérez de Pipaón M; Cuenca-Estrella M; ; ;
    Clin Infect Dis; 2014 May; 58(10):1413-21. PubMed ID: 24642553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of therapeutic strategies on the prognosis of candidemia in the ICU.
    Puig-Asensio M; Pemán J; Zaragoza R; Garnacho-Montero J; Martín-Mazuelos E; Cuenca-Estrella M; Almirante B; ; ; ;
    Crit Care Med; 2014 Jun; 42(6):1423-32. PubMed ID: 24557426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial susceptibility and clinical outcomes of Candida parapsilosis bloodstream infections in a tertiary teaching hospital in Northern Taiwan.
    Lin CC; Liu CP; Hsieh FC; Lee CM; Wang WS
    J Microbiol Immunol Infect; 2015 Oct; 48(5):552-8. PubMed ID: 25315213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology and predictive factors for early and late mortality in Candida bloodstream infections: a population-based surveillance in Spain.
    Puig-Asensio M; Padilla B; Garnacho-Montero J; Zaragoza O; Aguado JM; Zaragoza R; Montejo M; Muñoz P; Ruiz-Camps I; Cuenca-Estrella M; Almirante B; ; ;
    Clin Microbiol Infect; 2014 Apr; 20(4):O245-54. PubMed ID: 24125548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008-2009).
    Pfaller MA; Messer SA; Moet GJ; Jones RN; Castanheira M
    Int J Antimicrob Agents; 2011 Jul; 38(1):65-9. PubMed ID: 21514797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antifungal susceptibility testing of a 10-year collection of Candida spp. isolated from patients with candidemia.
    Iatta R; Caggiano G; Cuna T; Montagna MT
    J Chemother; 2011 Apr; 23(2):92-6. PubMed ID: 21571625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology, risk factor, species distribution, antifungal resistance and outcome of Candidemia at a single French hospital: a 7-year study.
    Tadec L; Talarmin JP; Gastinne T; Bretonnière C; Miegeville M; Le Pape P; Morio F
    Mycoses; 2016 May; 59(5):296-303. PubMed ID: 26806101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology and outcome of candidaemia in patients with oncological and haematological malignancies: results from a population-based surveillance in Spain.
    Puig-Asensio M; Ruiz-Camps I; Fernández-Ruiz M; Aguado JM; Muñoz P; Valerio M; Delgado-Iribarren A; Merino P; Bereciartua E; Fortún J; Cuenca-Estrella M; Almirante B; ; ;
    Clin Microbiol Infect; 2015 May; 21(5):491.e1-10. PubMed ID: 25703212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of fluconazole susceptibility on the outcome of patients with candidaemia: data from a population-based surveillance.
    Fernández-Ruiz M; Guinea J; Lora-Pablos D; Zaragoza Ó; Puig-Asensio M; Almirante B; Cuenca-Estrella M; Aguado JM; ;
    Clin Microbiol Infect; 2017 Sep; 23(9):672.e1-672.e11. PubMed ID: 28143788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alarming Increase of Azole-Resistant Candida Causing Blood Stream Infections in Oncology Patients in Egypt.
    El-Mahallawy HA; Abdelfattah NE; Wassef MA; Abdel-Hamid RM
    Curr Microbiol; 2023 Oct; 80(11):362. PubMed ID: 37796322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis on clinical characteristics and drug resistance of Candida parapsilosis bloodstream infections in West China Hospital, China, from 2012 to 2015.
    Liu Y; Kang M; Ye H; Zong Z; Lv X
    J Mycol Med; 2018 Mar; 28(1):222-226. PubMed ID: 29254811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Candida tropicalis fungaemia: incidence, risk factors and mortality in a general hospital.
    Muñoz P; Giannella M; Fanciulli C; Guinea J; Valerio M; Rojas L; Rodríguez-Créixems M; Bouza E
    Clin Microbiol Infect; 2011 Oct; 17(10):1538-45. PubMed ID: 20718804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics of Candida tropicalis fungaemia with reduced triazole susceptibility in Taiwan: a multicentre study.
    Liu WL; Huang YT; Hsieh MH; Hii IM; Lee YL; Ho MW; Liu CE; Chen YH; Wang FD
    Int J Antimicrob Agents; 2019 Feb; 53(2):185-189. PubMed ID: 30722962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Epidemiology, species, antifungal resistance and outcome of candidemia in a university hospital in Buenos Aires, Argentina for 16 years].
    Tiraboschi IN; Pozzi NC; Farías L; García S; Fernández NB
    Rev Chilena Infectol; 2017 Oct; 34(5):431-440. PubMed ID: 29488584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Candida bloodstream infection among children hospitalised in three public-sector hospitals in the Metro West region of Cape Town, South Africa.
    Gebremicael MN; Nuttall JJC; Tootla HD; Khumalo A; Tooke L; Salie S; Muloiwa R; Rhoda N; Basera W; Eley BS
    BMC Infect Dis; 2023 Feb; 23(1):67. PubMed ID: 36737689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatal candidemia caused by azole-resistant Candida tropicalis in patients with hematological malignancies.
    Chong Y; Shimoda S; Yakushiji H; Ito Y; Miyamoto T; Shimono N; Kamimura T; Akashi K
    J Infect Chemother; 2012 Oct; 18(5):741-6. PubMed ID: 22526385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nosocomial bloodstream infections due to Candida spp. in the USA: species distribution, clinical features and antifungal susceptibilities.
    Wisplinghoff H; Ebbers J; Geurtz L; Stefanik D; Major Y; Edmond MB; Wenzel RP; Seifert H
    Int J Antimicrob Agents; 2014 Jan; 43(1):78-81. PubMed ID: 24182454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of yeasts in bloodstream infection: Epidemiology and predisposing factors of Candidaemia in adult patients at a university hospital (2010-2014).
    Pongrácz J; Juhász E; Iván M; Kristóf K
    Acta Microbiol Immunol Hung; 2015 Sep; 62(3):317-29. PubMed ID: 26551574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.